Related Articles by Review for PMID: 23565115

Year	Number of Results
1988	1
1989	1
1993	1
1997	1
1998	2
1999	1
2001	2
2002	1
2003	2
2007	1
2009	2
2010	3
2011	3
2012	2
2013	4
2014	3
2015	7
2017	4
2018	3
2019	5
2020	1
2021	5
2024	0

1

Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Kollmann TR. Kollmann TR. Front Immunol. 2013 Apr 2;4:81. doi: 10.3389/fimmu.2013.00081. eCollection 2013. Front Immunol. 2013. PMID: 23565115 Free PMC article.

2

Recent advances of vaccine adjuvants for infectious diseases.

Lee S, Nguyen MT. Lee S, et al. Immune Netw. 2015 Apr;15(2):51-7. doi: 10.4110/in.2015.15.2.51. Epub 2015 Apr 23. Immune Netw. 2015. PMID: 25922593 Free PMC article. Review.

3

Vaccine adjuvants: putting innate immunity to work.

Coffman RL, Sher A, Seder RA. Coffman RL, et al. Immunity. 2010 Oct 29;33(4):492-503. doi: 10.1016/j.immuni.2010.10.002. Immunity. 2010. PMID: 21029960 Free PMC article. Review.

4

Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants.

Sepulveda-Crespo D, Resino S, Martinez I. Sepulveda-Crespo D, et al. Vaccines (Basel). 2020 Jun 17;8(2):313. doi: 10.3390/vaccines8020313. Vaccines (Basel). 2020. PMID: 32560440 Free PMC article. Review.

5

Vaccination strategies in developing countries.

Poore P. Poore P. Vaccine. 1988 Oct;6(5):393-8. doi: 10.1016/0264-410x(88)90136-3. Vaccine. 1988. PMID: 3057759 Review.

6

Vaccine adjuvant properties of probiotic bacteria.

Licciardi PV, Tang ML. Licciardi PV, et al. Discov Med. 2011 Dec;12(67):525-33. Discov Med. 2011. PMID: 22204769 Free article. Review.

7

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.

8

Immune response to vaccine adjuvants during the first year of life.

Levy O, Goriely S, Kollmann TR. Levy O, et al. Vaccine. 2013 May 17;31(21):2500-5. doi: 10.1016/j.vaccine.2012.10.016. Epub 2012 Oct 18. Vaccine. 2013. PMID: 23085363 Free PMC article. Review.

9

Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.

Laupèze B, Hervé C, Di Pasquale A, Tavares Da Silva F. Laupèze B, et al. Vaccine. 2019 Sep 10;37(38):5670-5680. doi: 10.1016/j.vaccine.2019.07.098. Epub 2019 Aug 13. Vaccine. 2019. PMID: 31420171 Free article. Review.

10

Trends in vaccine adjuvants.

Schijns VE, Lavelle EC. Schijns VE, et al. Expert Rev Vaccines. 2011 Apr;10(4):539-50. doi: 10.1586/erv.11.21. Expert Rev Vaccines. 2011. PMID: 21506650 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year